Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells. Duangjai, A; Luo, K; Zhou, Y; Yang, J; and KOPECEK, J Eur J Pharm Biopharm, 87(1):187--196, May, 2014. bibtex @article{ Duangjai:2014fxa,
author = {Duangjai, A and Luo, K and Zhou, Y and Yang, J and KOPECEK, J},
title = {{Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells}},
journal = {Eur J Pharm Biopharm},
year = {2014},
volume = {87},
number = {1},
pages = {187--196},
month = {May},
annote = {Duangjai, Acharaporn
Luo, Kui
Zhou, Yan
Yang, Jiyuan
Kopecek, Jindrich
eng
P30 CA042014/CA/NCI NIH HHS/
R01 CA051578/CA/NCI NIH HHS/
R01 CA51578/CA/NCI NIH HHS/
R41 CA156933/CA/NCI NIH HHS/
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Netherlands
2013/12/10 06:00
Eur J Pharm Biopharm. 2014 May;87(1):187-96. doi: 10.1016/j.ejpb.2013.11.008. Epub 2013 Dec 4.}
}